Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

CEC levels may be a useful marker for predicting prostate cancer progression.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Lipase H is important for hair follicle function and shaping hair fibers.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Lotions release minoxidil better than creams, with a recommended mix of propylene glycol, water, and ethanol improving effectiveness.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

The document is a detailed medical reference on skin and genetic disorders.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.